1、2020 Health for Humanity ReportProgress in SustainabilityContentsABOVE:During the COVID-19 pandemic,community healthcare workers in Peru traveled door-to-door to reach children with VERMOX Chewable tablets for treatment of intestinal worms.The medicine is donated by Johnson&Johnson and implemented b
2、y INMED Partnerships for Children.Photo by INMED Partnerships for Children.FRONT COVER:Jacquelyn W.,Senior Warehouse Operator,celebrating the first outbound shipment of the Johnson&Johnson COVID-19 vaccine.Report overviewThis Report details the progress of the Johnson&Johnson Family of Companies in
3、sustainability.It is also our primary source of annual disclosure on environmental,social and governance(ESG)performance and should be reviewed in conjunction with disclosures on the ESG Policies&Positions page.Data in this Report cover the period between January 1,2020,and December 31,2020,unless o
4、therwise noted.Reporting on other matters specific to financial performance of the Company and its subsidiaries can be found in our 2020 Annual Report.For more information and the Cautionary Note Regarding Forward-Looking Statements,please see About this Report.To read this report online,visit .Mess
5、age from Our Chairman and CEO 2020 Year in Brief Our RecognitionsOur Approach Health for Humanity Strategy&Goals Sustainability Governance Sustainability Priorities United in Defeating COVID-19 Caring for Patients Supporting the Front Lines of Care Protecting Employees Supply Chain Resilience Better
6、 Health for All Innovation Global Public Health Strategy Access&Affordability Strengthening Health Systems Responsible Business Practices Ethics&Values Our People Product Quality&Safety Environmental Health Responsible Supply Base Reporting Hub ESG Summary Performance Data GRI Content Index GRI Cult